Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Rt-PA Dose-effect Relationship on ICH Evacuation

NCT02472574 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT02472574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02472574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Rt-PA Dose-effect Relationship on ICH Evacuation
Lead sponsor
Tongji Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2015
Completion date
June 30, 2018
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive intracerebral hemorrhage